Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > Anticancer Activity of Metallodrugs

<< Previous

Bullboard Posts

Next >>

Comment by Tarbabyon Jul 31, 2024 10:41am

273 Views

Post# 36156159

RE:Anticancer Activity of Metallodrugs

Good analysis..
But you did not mention that the NEW PDT is Xray PDT.
The xrays turn into photons deep in a body to trigger the drug to kill cancer....Its a New ball game...huge future coming.
Check out Fox Chase clinical trial using xrays for PDT.
Munster University in Germany has an xray Pdt trial going also.
Plus a few others.
But none have Rutherrin...we do.

<< Previous

Bullboard Posts

Next >>

E3 inches closer to Alberta's first lithium production plant